The inhibitory activity of typified propolis against Enterococcus species

Bernard J Moncla1, Peter W Guevara, James A Wallace

  • 1School of Dental Medicine, University of Pittsburgh, Departments of Oral Biology and Endodontics, 3501 Terrace Street, Pittsburgh, PA 15260, USA.

Insights

This study shows that propolis, a natural bee product, effectively inhibits Enterococcus bacteria from human and animal sources. Brazilian propolis demonstrated significant antimicrobial activity against Enterococcus faecium and Enterococcus faecalis, including those from endodontic treatments.

Area of Science:

  • Natural Products Chemistry
  • Microbiology
  • Endodontics

Background:

  • Propolis is a natural bee-derived resin with known antimicrobial properties.
  • Enterococcus species are significant pathogens in human and animal infections, including refractory endodontic cases.
  • Understanding the antimicrobial spectrum of propolis is crucial for its therapeutic applications.

Purpose of the Study:

  • To evaluate the antimicrobial activity of propolis against various Enterococcus isolates.
  • To characterize the chemical composition of the propolis used.
  • To determine the minimum inhibitory concentrations (MIC) of propolis against susceptible bacteria.

Main Methods:

  • Propolis typification using high-performance liquid chromatography (HPLC) to identify key constituents like prenylated compounds, cinnamic acid derivatives, and flavonoids.
  • Determination of Minimum Inhibitory Concentrations (MIC) via the agar dilution method.
  • Testing against Enterococcus isolates from human, animal (pig-tailed macaques), refractory endodontic treatments, and Lactobacillus-containing food supplements.

Main Results:

  • HPLC analysis confirmed prenylated compounds, cinnamic acid derivatives, and flavonoids as major propolis constituents.
  • All human and animal Enterococcus isolates exhibited MIC values of 1600 microg/mL.
  • Propolis demonstrated inhibitory effects on Enterococcal species from both human and animal origins.
  • Human isolates of Enterococcus faecium and Enterococcus faecalis, particularly from refractory endodontic cases, were found to be susceptible to Brazilian propolis.

Conclusions:

  • Brazilian propolis possesses significant antimicrobial activity against human and animal Enterococcus isolates.
  • Propolis is a viable natural agent for combating Enterococcus infections, including challenging endodontic cases.
  • Further research into propolis-based therapeutics for infectious diseases is warranted.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...